PEspeaks

Feb 06, 2018
Pharmaceutical Executive
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
Feb 05, 2018
Amid the clamor for government action to curb prescription drug prices, a more collaborative effort aims to consider the full range of healthcare services and rates that affect spending in this area.
Feb 04, 2018
Professor Carole Longson's move from NICE to the ABPI is another appointment that helps to square the balance between UK industry and Government. Leela Barham reports.
Feb 02, 2018
Pharmaceutical Executive
Are the technologies and assumptions at the heart of healthcare AI trustworthy?
Jan 30, 2018
Pharmaceutical Executive
But how much better would our creative be if we took the time to really listen to what our clients are saying – and what they are not saying – rather than reading between the lines of an RFP?
Jan 25, 2018
Pharmaceutical Executive
Marc O'Connor discusses healthcare services, provider integration, and more insights from the 2018 JP Morgan healthcare conference.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Jan 18, 2018
Manish Gupta discuss the current strengths and weaknesses of artificial intelligence applications in life sciences.
Jan 12, 2018
Pharmaceutical Executive
This post highlights the benefits of a new IT favorite for healthcare marketing, trigger emails.
Jan 12, 2018
Shared understanding of both risks and benefits to all parties in the healthcare continuum is essential in order to deliver more value, write Vickie Andros and Jake Caines.
native1_300x100
lorem ipsum